Concord Biotech (BOM:543960) Shares Outstanding (Basic Average): 105 Mil (As of Mar. 2026)


BOM:543960 Concord Biotech Ltd BOM:543960
67 GF Score
Price ₹1,277.85
GF Value ₹1,640.84
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Concord Biotech Shares Outstanding (Basic Average)?

Concord Biotech BOM:543960 +1.24% 67 Shares Outstanding (Basic Average) is 105 Mil as of Mar. 2026. GuruFocus rates BOM:543960 with a GF Score™ of 67/100 and a GF Value™ of ₹1,640.84 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Concord Biotech's average basic shares outstanding for the quarter that ended in Mar. 2026 was 105 Mil.


Concord Biotech  (BOM:543960) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Concord Biotech Shares Outstanding (Basic Average) Related Terms


Concord Biotech Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Concord Biotech's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Biotech Shares Outstanding (Basic Average) Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial 104.62 104.62 104.62 104.63 105.29

Concord Biotech Quarterly Data
Mar20 Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.61 104.65 104.58 104.67 104.95
BOM:543960
67GF Score
Concord Biotech Ltd BOM:543960
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Biotech Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 105 Mil mean?
Concord Biotech (BOM:543960) has a Shares Outstanding (Basic Average) of 105 Mil as of Mar. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Concord Biotech and its competitors.
Is Concord Biotech's Shares Outstanding (Basic Average) too high?
Concord Biotech's current Shares Outstanding (Basic Average) is 105 Mil. Overall, Concord Biotech has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Concord Biotech's Shares Outstanding (Basic Average) compare to VRTX and REGN?
Concord Biotech's Shares Outstanding (Basic Average) of 105 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Biotechnology company?
A good Shares Outstanding (Basic Average) depends on the Biotechnology industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Concord Biotech and its competitors. Concord Biotech's current Shares Outstanding (Basic Average) is 105 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Biotech stock overvalued right now?
Based on GuruFocus' analysis, Concord Biotech (BOM:543960) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,640.84, compared to a current price of ₹1,277.85 — trading 22.1% below its estimated fair value. The current Shares Outstanding (Basic Average) is 105 Mil. Concord Biotech's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Concord Biotech (BOM:543960), the current Shares Outstanding (Basic Average) is 105 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Biotech (BOM:543960) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Biotech stock appears to be undervalued. The current stock price of ₹1,277.85 is trading 22.1% below its estimated GF Value™ of ₹1,640.84. GuruFocus considers Concord Biotech to be Modestly Undervalued.

Key valuation signals for BOM:543960:

  • Shares Outstanding (Basic Average): 105 Mil
  • GF Value™: ₹1,640.84 vs. price of ₹1,277.85 (22.1% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BOM:543960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Concord Biotech Business Description

Other Exchanges CONCORDBIO:India
Address Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products. Geographically Company operates in two segments within India and outside India, having majority revenue from India.
67GF Score

Get the complete analysis for BOM:543960

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,277.85
Price
₹1,640.84
GF Value